| 764568 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
64 A cloning and expression system of the neoantigen-specific TCRs from tumor-infiltrating lymphocytes by single-cell sequencing of paired TCRα and TCRβ chains |
2021-11-01 |
10.1136/jitc-2021-sitc2021.064 |
Kobayashi Yukari, Nagaoka Koji, Kubo Kaori, Nishie Toshikazu, Okamoto Sachiko, Enoki Tatsuji, Mineno Junichi, Sato Yasuyoshi, Takahashi Shunji, Nakajima Jun, Kakimi Kazuhiro |
| 764567 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
62 Applying machine vision to empower preclinical development of cell engager and adoptive cell therapeutics in patient-derived organoid models of solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.062 |
Khare Sonal, Ho Chi-Sing, Kannan Madhavi, Larsen Brian, Mapes Brandon, Shaxted Jenna, Venkataraman Jagadish, Salahudeen Ameen |
| 764566 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
813 CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
2021-11-01 |
10.1136/jitc-2021-sitc2021.813 |
Liu Mingyue, Wang Xu, Zhang Peng, Su Juanjuan, Du Xuexiang, Zhang Yan, Liu Yang, Zheng Pan |
| 764565 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
812 Erythema nodosum-like toxicity in an immunotherapy treated patient is accompanied by oligoclonal memory activated CD4 T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.812 |
Sun Xiaopeng, Axelrod Margaret, Wang Yu, Violeta Sanchez, Gonzalez-Ericsson Paula, Johnson Douglas, Balko Justin |
| 764564 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
811 Allelic variation in Human Leukocyte Antigen class II genes is associated with pneumonitis risk in cancer patients treated with immune checkpoint inhibitors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.811 |
Saha Ashis, Spencer Christine, Khan Zia, Carroll Jonathan, Arellano Claudia Yanez, Hunkapiller Julie, Bayless Nicholas, Nissola Leonardo, Wallace Roslyn, Mellman Ira, Mohindra Rajat, Bucktrout Samantha, Sandhu Shahneen, Scott Chandler G., Hammer Christian, Hammer Christian |
| 764563 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
810 Impact of immune-related adverse event development on overall survival in hospitalized lung cancer patients |
2021-11-01 |
10.1136/jitc-2021-sitc2021.810 |
Olson Eric, Russell Greg, Lantz Jeffrey, Dothard Andy, Aggarwal Vanya, Lycan Thomas |
| 764562 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
807 Immunotherapy related adverse events: a single center experience |
2021-11-01 |
10.1136/jitc-2021-sitc2021.807 |
Yang Wei, Rowe Julie, Lee Sophia, Zhang Jing, Rahbar Mohammad |
| 764561 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
806 PD-1 blockade affects inflammation and metabolic flexibility to potentially mediate cardiac immune-related adverse events |
2021-11-01 |
10.1136/jitc-2021-sitc2021.806 |
Bronson Steven, Stirling Elizabeth, Westwood Brian, Triozzi Pierre, Soto-Pantoja David |
| 764560 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
805 Clonal, activated CD8+ T cells recognizing cardiac alpha-myosin drive immune checkpoint inhibitor associated myocarditis in mice |
2021-11-01 |
10.1136/jitc-2021-sitc2021.805 |
Axelrod Margaret, Meijers Wouter, Tannous Elie, Sun Xiaopeng, Qin Juan, Sugiura Ayaka, Wescott Elizabeth, Screever Elles, Wei Spencer, Opalenik Susan, Zhang Yueli, Johnson Douglas, Allison James, Moslehi Javid, Balko Justin |
| 764559 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.804 |
Tiu Bruce, Zubiri Leyre, Iheke James, Pahalyants Vartan, Theodosakis Nicholas, Ugwu-Dike Pearl, Seo Jayhyun, Tang Kimberly, Sullivan Ryan, Mooradian Meghan, Semenov Yevgeniy, Reynolds Kerry |
